Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bergsagel

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Stem Cells (Dayton, Ohio)|August 1, 1995
The incidence and epidemiology of plasma cell neoplasmsD Bergsagel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Progress in the treatment of plasma cell myeloma?D Bergsagel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Small-cell lung cancer is still a problemD Bergsagel, R Feld
British Journal of Cancer|January 1, 1988
A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patientsA Belch, W Shelley, D Bergsagel, et al.
Cancer Treatment Reports|October 1, 1987
Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myelomaK Wilson, W Shelley, A Belch, et al.
British Journal of Haematology|November 1, 1992
Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials GroupG P Browman, A Belch, J Skillings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trialL Yelle, D Bergsagel, V Basco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials GroupG P Browman, D Bergsagel, D Sicheri, et al.
Cancer|November 13, 2014
Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link?Fuad El Rassi, John D Bergsagel, Martha Arellano, et al.
Leukemia & Lymphoma|May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myelomaR P Gale, R E Park, R W Dubois, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Stem Cells (Dayton, Ohio)|August 1, 1995
The incidence and epidemiology of plasma cell neoplasmsD Bergsagel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Progress in the treatment of plasma cell myeloma?D Bergsagel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Small-cell lung cancer is still a problemD Bergsagel, R Feld
British Journal of Cancer|January 1, 1988
A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patientsA Belch, W Shelley, D Bergsagel, et al.
Cancer Treatment Reports|October 1, 1987
Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myelomaK Wilson, W Shelley, A Belch, et al.
British Journal of Haematology|November 1, 1992
Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials GroupG P Browman, A Belch, J Skillings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trialL Yelle, D Bergsagel, V Basco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials GroupG P Browman, D Bergsagel, D Sicheri, et al.
Cancer|November 13, 2014
Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link?Fuad El Rassi, John D Bergsagel, Martha Arellano, et al.
Leukemia & Lymphoma|May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myelomaR P Gale, R E Park, R W Dubois, et al.
Pageof 2